Feeling Trapped by your Current RTSM Solution? How to exit your provider with minimal disruption.
Doylestown, PA – March 13, 2025 – Korio, Inc., the pioneering Randomization & Trial Supply Management (RTSM) technology company, today announced the successful implementation of its mid-study migration solution, enabling sponsors to change RTSM vendors during ongoing clinical trials with minimal risk to data integrity and study operations.
The company has developed and validated a data migration toolkit specifically designed to support sponsors who find themselves dissatisfied with their current RTSM provider but hesitant to make a change mid-study due to perceived risks.
“Most of us would not accept using the wrong solution for months or years for relatively minor aspects of our lives, let alone for critical services. Sponsors have historically been reluctant to switch RTSM vendors during active studies, even when facing significant challenges with their current provider,” said Chuck Harris, Co-founder and COO of Korio. “We’ve now completed multiple successful migrations for complex global studies, demonstrating that our structured platform approach can safely transfer participant and supply data with minimal disruption to ongoing operations.”
The company’s migration solution addresses a common industry challenge where sponsors often feel trapped with underperforming vendors for months if not years until study completion. Korio’s approach includes three key components:
- Platform architecture ensures consistent data structures across studies, allowing for accurate mapping and ingestion of data from other RTSM systems with reduced risk to data integrity.
- The company has developed a specialized migration toolkit that enables efficient review, validation, and reconciliation of data prior to system cutover.
- Korio’s project management team guides sponsors through a comprehensive testing process where they can view and use their actual study data in the Korio system during User Acceptance Testing, simulating the go-live experience before committing to the transition.
“The moment of transition between systems is understandably concerning for sponsors,” Harris explained. “Will in-transit shipments be tracked correctly? Will site staff be able to access complete participant histories? Our approach addresses these concerns by allowing sponsors to thoroughly test the migrated data before go-live, eliminating surprises during cutover.”
Industry experts note that mid-study migrations typically only occur when a vendor has significantly failed to meet expectations. Common challenges that drive sponsors to consider switching include unintuitive interfaces requiring excessive workarounds, high project manager turnover, unresponsive support, system limitations, and lengthy implementation times for changes.
Korio has successfully completed migrations for multiple global clinical trials and has refined the process to make it both safer and more efficient. This capability allows sponsors to access Korio’s RTSM solution without waiting for studies to conclude.
About Korio
Korio is the Randomization & Trial Supply Management (RTSM) platform for quality, speed and reliability, backed by decades of expertise so you can be Ready for the Trials Ahead℠. Adapting faster to protocol changes. Easily surfacing audit trail and cross-portfolio data. Rapidly flagging integration disruptions – and when you need guidance, providing access to knowledgeable and responsive RTSM experts all on a simple, user-friendly platform. No matter what trials you may face, Korio is built ready so nothing disrupts your journey to clinical trial success. To learn more visit korioclinical.com.